APAC Non-Small Cell Lung Cancer Therapeutic Market, Market Segmented, by Drug (Alimta, Iressa, Avastin, Tarceva, Zykadia, Tagrisso, Xalkori, and Cyramza)- Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138351
- Pages: 200
-
Format:
Report Overview
The APAC Non-Small Cell Lung Cancer Therapeutics Market, market size stood at around USD $4.9 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
NSCLCis any type of epitheliallung cancerother thansmall cell lung cancer(SCLC). The most common types ofNSCLCare squamouscell carcinoma, largecell carcinoma, andadenocarcinoma, but there are several other types that occur less frequently, and all types can occur in unusual histologic variants. Non-Small Cell Lung Cancer (NSCLC) is the most common cancer and cause of cancer-related mortality
Market Drivers
Over half of the incident cases of NSCLC are diagnosed in patients over the age of 65 - a high-risk age range for lung cancer. As the aged population is projected to increase, the prevalence of lung cancer is anticipated to increase, thereby acting as a driver for revenue growth. The poor prognosis, particularly for patients with advanced disease, has created a pressing need for improved therapeutic options
1. APAC Non-Small Cell Lung Cancer Therapeutics Market Overview
A. Market Size
2. APAC Non-Small Cell Lung Cancer Therapeutics Growth Drivers
A. Over half of the incident cases of NSCLC are diagnosed in patients over the age of 65 - a high-risk age range for lung cancer
B. As the aged population is projected to increase, the prevalence of lung cancer is anticipated to increase
3. APAC Hodgkins lymphoma Treatment Market Segmentation
A. By Drug
I. Alimta
II. Iressa
III. Avastin
IV. Tarceva
V. Zykadia
VI. Tagrisso
VII. Xalkori
VIII. Cyramza
4. Hodgkins lymphoma Treatment Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Merck & Co. Inc., Company overview, Product & Services, Strategies & Financials
B. Bristol-Myers Squibb, Company overview, Product & Services, Strategies & Financials
C. Keytruda, Inc, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
